WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke BINA wurde als Wortmarke am 10.12.2015 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1295156 |
| Registernummer | 302015041943 |
| Länder | 
|
| Basismarke |
Nr. 30 2015 041 943,
19. August 2015
|
| Anmeldedatum | 10. Dezember 2015 |
| Ablaufdatum | 10. Dezember 2025 |
Markeninhaber
Sandhofer Strasse 116
68305 Mannheim
DE
68305 Mannheim
DE
Markenvertreter
4070 Basel
CH
Waren und Dienstleistungen
09
Downloadable computer databases containing information in
the field of genomics, cancer research and cancer
treatments; downloadable software for accessing, organizing,
interpreting and analyzing information from databases in the
fields of genomics, cancer research and cancer treatments;
laboratory apparatus for sequencing of genomic DNA; computer
databases, in particular biomedical computer databases
containing information about clinical, molecular, scientific
and patient specific data, in particular for the
integration, interpretation and analysis of cancer genomic
information, biomarker information; computer software for
authorizing access to these biomedical databases, in
particular application software, interface software,
software drives, data communication software and interactive
computer software
42
Electronic data collection for analytical and clinical
purposes, in particular the collection and systematic
sorting of specific molecular, genomic and/or clinical data
relating to genomic changes, namely, cancer genomic changes,
of an individual, namely of a cancer patient; providing
scientific information through the collection and analysis
of genetic information and information regarding the
treatment of cancer and other diseases and disorders;
electronic data collection for analytical purposes, in
particular the collection of mathematical and statistical
data, clinical data, genomic data and data of clinical
studies relating to the patients clinical responses to drug
treatments and treatment regimes; providing scientific
advice in the fields of cancer biology, cancer treatment,
pharmaceutical side effects, genomics, cancer medicine and
translational medicine; providing scientific analysis and
analysis services in the field of next generation sequencing
(NGS), namely, the analysis and interpretation of genomic
data obtained from cancer patients; providing scientific
information on patients' genomic changes that contribute to
an unique cancer disease; providing research information
about drug safety and drug compatibility in relation to
cancer therapy and the treatment of patients; scientific
consulting services in the fields of pharmaceuticals and
genetics, in particular conducting scientific research in
drug safety and dosage assessment and drug compatibility
studies in the field of cancer treatment therapy for others;
electronic storage of medical data and information for
physicians and healthcare professionals; providing an
on-line, non-downloadable computer platform for purposes of
storing and providing information about an individual's
cancer profile and genomic changes of individuals to enable
physicians and healthcare professionals to optimize
treatment in clinical practice
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 29. September 2021 | 2021/41 Gaz | SG | RAW: No Effect Limitation |
| 03. Dezember 2019 | 2019/50 Gaz | CN | Ablehnung |
| 13. September 2019 | 2019/38 Gaz | Korrektur | |
| 19. Juli 2019 | 2019/33 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 04. Oktober 2018 | 2018/44 Gaz | AU | Ablehnung |
| 04. Oktober 2018 | 2018/44 Gaz | AU | Ablehnung |
| 10. August 2018 | 2018/32 Gaz | NZ | Ablehnung |
| 04. Juli 2018 | 2021/24 Gaz | RAW: Limitation | |
| 05. Juni 2018 | 2018/24 Gaz | SG | Ablehnung |
| 02. April 2018 | 2018/17 Gaz | IN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 09. Februar 2018 | 2018/7 Gaz | Korrektur | |
| 09. Februar 2018 | 2018/7 Gaz | Korrektur | |
| 07. Dezember 2017 | 2017/50 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 08. November 2017 | 2017/45 Gaz | MX | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. Oktober 2017 | 2017/41 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. August 2017 | 2017/34 Gaz | JP | Ablehnung |
| 20. April 2017 | 2017/16 Gaz | MX | Ablehnung |
| 10. April 2017 | 2017/19 Gaz | IN | Ablehnung |
| 22. März 2017 | 2017/13 Gaz | RU | Ablehnung |
| 21. März 2017 | 2017/12 Gaz | CH | Ablehnung |
| 13. Januar 2017 | 2017/3 Gaz | NO | Ablehnung |
| 20. Dezember 2016 | 2017/18 Gaz | IS | Ablehnung |
| 12. Dezember 2016 | 2017/12 Gaz | CN | Ablehnung |
| 06. November 2016 | 2017/6 Gaz | TR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. November 2016 | 2017/11 Gaz | RAW: Limitation | |
| 21. Oktober 2016 | 2016/44 Gaz | KR | Ablehnung |
| 29. September 2016 | 2016/42 Gaz | JP | Ablehnung |
| 16. September 2016 | 2016/39 Gaz | EM | Ablehnung |
| 11. Juli 2016 | 2016/31 Gaz | TR | Ablehnung |
| 10. Dezember 2015 | 2016/14 Gaz | DE | Eintragung |
ID: 141295156